Real-world outcomes after switching from standard therapy to efgartigimod in five patients with chronic inflammatory demyelinating polyradiculoneuropathy: a case series study in Japan
Study Overview This case series investigates the effects of transitioning from standard therapy to efgartigimod in patients diagnosed with chronic […]

